Atlas Trials

Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes

Clinical trial NCT00593255 · COMPLETED

Trial details

NCT number
NCT00593255
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Start date
2004-07-01
Primary completion
2005-04-01
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.